The Deal
Sunday, November 22, 
3:39 am

Hiring: Centerview grabs Merrill healthcare M&A bankers

[ Share ]  [ E-mail ]  [ Leave a Comment ]
The healthcare industry is restructuring itself to reduce its reliance on blockbuster drugs while trying to gain a foothold in the generics market and the emerging markets. We've seen megamergers and bolt-ons, and there's more to come. New York boutique investment bank Centerview Partners LLC is right on top of that development as well as a hiring trend: bankers at huge investment banks trekking to boutiques.

And a culture clash (as well as shrinking bonuses due to watchful government and public eyes [see: TARP money]) at the recently merged Bank of America Merrill Lynch is fueling the move to smaller banks. The latest high-profile moves include veteran healthcare dealmaking trio Alan Hartman, Richard Girling and Mark Robinson going to Centerview as it opens offices in London and San Francisco.

Hartman was Merrill's head of Americas mergers and acquisitions and global head of healthcare M&A, and Girling and Robinson were global co-heads of Merrill's healthcare investment banking group. Hartman will work from New York, while Girling and Robinson will be senior partners in the London and San Francisco offices, respectively. Hartman joined Merrill in 1993; Girling and Robinson joined in 1998.

Following Merrill's acquisition by Bank of America Corp. (NYSE:BAC), Hartman was appointed head of Americas M&A for the combined organization, Girling was named head of the merged Europe, Middle East and Asia and Asia-Pacific healthcare practices, and Robinson became co-head of Americas healthcare investment banking.

Collectively, the trio has worked on some notable deals, including Pfizer Inc.'s (NYSE:PFE) $68 billion planned acquisition of Wyeth (NYSE:WYE), Sanofi-Synthelabo's $63 billion acquisition of Aventis, the $25 billion leveraged buyout of Alliance Boots plc, AstraZeneca plc's (NYSE:AZN) $15 billion acquisition of MedImmune, Idec Pharmaceuticals in its $6 billion merger with Biogen and Boston Scientific Corp.'s (NYSE:BSX) $25 billion acquisition of Guidant Corp.

A Wall Street Journal reporter picked up this nugget from Centerview co-founder Blair Effron, who said, "It's been fun going back to a style of investment banking that a lot of us grew up in. Changes in the industry mean we're able to recruit more of the best talent." - Baz Hiralal



Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Deal Economy 2010: Avaya's Ali on digesting Nortel

Avaya Inc.'s Mohamad Ali on the company's next target.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.